Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.
Saved in:
| Title: | Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. |
|---|---|
| Authors: | Nikolova Z; Novartis Oncology, Basel, Switzerland. zariana.nikolova@pharma.novartis.com, Peng B, Hubert M, Sieberling M, Keller U, Ho YY, Schran H, Capdeville R |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2004 May; Vol. 53 (5), pp. 433-8. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 15132131 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nikolova+Z%22">Nikolova Z</searchLink>; Novartis Oncology, Basel, Switzerland. zariana.nikolova@pharma.novartis.com<br /><searchLink fieldCode="AU" term="%22Peng+B%22">Peng B</searchLink><br /><searchLink fieldCode="AU" term="%22Hubert+M%22">Hubert M</searchLink><br /><searchLink fieldCode="AU" term="%22Sieberling+M%22">Sieberling M</searchLink><br /><searchLink fieldCode="AU" term="%22Keller+U%22">Keller U</searchLink><br /><searchLink fieldCode="AU" term="%22Ho+YY%22">Ho YY</searchLink><br /><searchLink fieldCode="AU" term="%22Schran+H%22">Schran H</searchLink><br /><searchLink fieldCode="AU" term="%22Capdeville+R%22">Capdeville R</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2004 May; Vol. 53 (5), pp. 433-8. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0344-5704 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15132131 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-003-0756-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 433 Titles: – TitleFull: Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nikolova Z – PersonEntity: Name: NameFull: Peng B – PersonEntity: Name: NameFull: Hubert M – PersonEntity: Name: NameFull: Sieberling M – PersonEntity: Name: NameFull: Keller U – PersonEntity: Name: NameFull: Ho YY – PersonEntity: Name: NameFull: Schran H – PersonEntity: Name: NameFull: Capdeville R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2004 May Type: published Y: 2004 Identifiers: – Type: issn-print Value: 0344-5704 Numbering: – Type: volume Value: 53 – Type: issue Value: 5 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |
